Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

Published:2011-06 Issue:9 Volume:47 Page:1312-1318
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yang Deok-Hwan,Min Jung-Joon,Song Ho-Chun,Jeong Yong Yeon,Chung Woong-Ki,Bae Soo-Young,Ahn Jae-Sook,Kim Yeo-Kyeoung,Bom Hee-Seung,Chung Ik-Joo,Kim Hyeoung-Joon,Lee Je-Jung

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?;Spaepen;J Clin Oncol,2001

2. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging;Jerusalem;Blood,1999

3. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin’s lymphoma-comparison with CT;Mikhaeel;Leuk Lymphoma,2000

4. Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin’s lymphoma and diffuse large B-cell lymphoma: a systematic review;Terasawa;J Clin Oncol,2009

5. Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?;Mikhaeel;Leuk Lymphoma,2009

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL);Nuklearmedizin - NuclearMedicine;2024-04-09

2. Predicting diffuse large B-cell lymphoma outcomes with lesion-to-liver maximum standardized uptake value for interim-treatment and end-of-treatment positron emission tomography-computed tomography;Quantitative Imaging in Medicine and Surgery;2023-10

3. The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma;Cancers;2023-09-07

4. A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy;Journal of Cancer Research and Clinical Oncology;2023-05-29

5. PET/CT in Non-Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05